<?xml version="1.0" encoding="UTF-8"?>
<results title="drug">
 <result pre="and therapeutic approaches to develop vaccines and drugs for COVID-19." exact="Chloroquine" post="Convalescent plasma (CP) COVID-19 Current diagnostics SARS-CoV-2 INTRODUCTION The"/>
 <result pre="diagnostics methods for accurate results to guide treatment options. Currently," exact="chloroquine" post="and hydroxychloroquine are the most-used drugs, which have been"/>
 <result pre="for accurate results to guide treatment options. Currently, chloroquine and" exact="hydroxychloroquine" post="are the most-used drugs, which have been discussed along"/>
 <result pre="(Table 3). CHLOROQUINE AS A THERAPEUTIC DRUG FOR HUMAN DISEASES" exact="Chloroquine" post="was first developed in the 1940s, as an aminoquinolone"/>
 <result pre="for the treatment of malaria (17). The chemical formula of" exact="chloroquine" post="is C18H6CIN3. Chloroquine was granted FDA approval on October"/>
 <result pre="of malaria (17). The chemical formula of chloroquine is C18H6CIN3." exact="Chloroquine" post="was granted FDA approval on October 31, 1949 (FDA,"/>
 <result pre="approval on October 31, 1949 (FDA, Approved Drug Products: Aralen" exact="Chloroquine" post="Oral Tablets). Chloroquine and its derivative, hydroxychloroquine, are very"/>
 <result pre="31, 1949 (FDA, Approved Drug Products: Aralen Chloroquine Oral Tablets)." exact="Chloroquine" post="and its derivative, hydroxychloroquine, are very closely related and"/>
 <result pre="related and used to treat malaria and rheumatologic conditions, respectively." exact="Hydroxychloroquine" post="is a disease-modifying anti-rheumatic drug, and it regulates the"/>
 <result pre="arthritis, discoid and systemic lupus erythematosus, and juvenile idiopathic arthritis." exact="Chloroquine" post="and hydroxychloroquine have been repurposed for the treatment of"/>
 <result pre="and systemic lupus erythematosus, and juvenile idiopathic arthritis. Chloroquine and" exact="hydroxychloroquine" post="have been repurposed for the treatment of several disease"/>
 <result pre="conditions, including HIV, Systemic lupus erythematosus, and rheumatoid arthritis (18)." exact="Chloroquine" post="is classified as an anti-malarial drug and has shown"/>
 <result pre="shown potential in the treatment of avian influenza A (19)." exact="Chloroquine" post="has been indicated to treat infections caused by P."/>
 <result pre="be used to treat extraintestinal amebiosis (FDA; Approved Drug Products:" exact="Chloroquine" post="Phosphate Oral tablets) and prophylaxis caused by Zika virus"/>
 <result pre="prophylaxis caused by Zika virus (20, 21). The anti-malarial drugs" exact="hydroxychloroquine" post="and chloroquine have demonstrated antiviral activity SARS-CoV-2 in vitro"/>
 <result pre="by Zika virus (20, 21). The anti-malarial drugs hydroxychloroquine and" exact="chloroquine" post="have demonstrated antiviral activity SARS-CoV-2 in vitro (22). A"/>
 <result pre="activity SARS-CoV-2 in vitro (22). A Chinese study found that" exact="chloroquine" post="will reduce the symptom duration, exacerbation of pneumonia, including"/>
 <result pre="the FDA has approved an emergency authorization for use of" exact="chloroquine" post="and hydroxychloroquine (FDA: Emergency Use Authorization Information). Chloroquine is"/>
 <result pre="has approved an emergency authorization for use of chloroquine and" exact="hydroxychloroquine" post="(FDA: Emergency Use Authorization Information). Chloroquine is currently undergoing"/>
 <result pre="use of chloroquine and hydroxychloroquine (FDA: Emergency Use Authorization Information)." exact="Chloroquine" post="is currently undergoing clinical trials for the treatment of"/>
 <result pre="principally used as an anti-malarial and autoimmune-treating drug (19, 24)." exact="Chloroquine" post="and its combination of drugs used in the treatment"/>
 <result pre="the treatment of COVID-19 has been listed in Table 4." exact="Hydroxychloroquine" post="and chloroquine are currently undergoing clinical trials to ensure"/>
 <result pre="of COVID-19 has been listed in Table 4. Hydroxychloroquine and" exact="chloroquine" post="are currently undergoing clinical trials to ensure their preventive"/>
 <result pre="to ensure their preventive action for SARS-CoV-2 infected patients (8)." exact="Chloroquine" post="diffuses to the cell passively through the cell membranes"/>
 <result pre="lysosomes, and Golgi vesicles, where it becomes protonated, trapping the" exact="chloroquine" post="in the organelle and raising the surrounding pH (25,"/>
 <result pre="using their activity for fusion and entry into the cell." exact="Chloroquine" post="does not affect the expression of ACE2 on cell"/>
 <result pre="for cell entry targeted by SARS-CoV and SARS-CoV-2 (26-28). The" exact="chloroquine" post="and hydroxychloroquine have various way to inhibit SARS-CoV-2 action."/>
 <result pre="entry targeted by SARS-CoV and SARS-CoV-2 (26-28). The chloroquine and" exact="hydroxychloroquine" post="have various way to inhibit SARS-CoV-2 action. Also, because"/>
 <result pre="the viral attachment to the human host receptors. Additionally, the" exact="chloroquine" post="can constrain the quinone reductase-2, which is an essential"/>
 <result pre="used as the receptor moieties by the SARS-CoV-2. Moreover, the" exact="chloroquine" post="obstructs the MAP-kinase, which results in SARS-CoV-2 virus molecular"/>
 <result pre="of the virus (26). Savarino et al. (29) hypothesized that" exact="chloroquine" post="might block the production of pro-inflammatory cytokines like interleukin-6"/>
 <result pre="blocking the pathway leading to ARDS. Additional assays demonstrated that" exact="chloroquine" post="functioned at both entries and post-entry stages of the"/>
 <result pre="cells. The in vitro study findings revealed that remdesivir and" exact="chloroquine" post="are highly effective in the control of COVID-19. Because"/>
 <result pre="with COVID-19 infection and who have no complications with the" exact="chloroquine" post="drug are advised to take 500 mg of chloroquine"/>
 <result pre="the chloroquine drug are advised to take 500 mg of" exact="chloroquine" post="two times a day for 10 days (31). The"/>
 <result pre="for 10 days (31). The ICMR recommends the use of" exact="hydroxychloroquine" post="for high-risk COVID-19 cases (32). In China and France,"/>
 <result pre="France, small studies provide some indications of possible benefits of" exact="chloroquine" post="phosphate against pneumonia caused by COVID-19, but need confirmation"/>
 <result pre="caused by COVID-19, but need confirmation through randomized trials (9)." exact="Chloroquine" post="also has been shown to have anti-viral as well"/>
 <result pre="the endosomal pH required for viral fusion (Fig. 2) (30)." exact="Azithromycin" post="has been suggested to act in combination with Chloroquine/hydroxychloroquine"/>
 <result pre="(31). Several in vitro studies reported the anti-viral activity of" exact="Chloroquine" post="and hydroxychloroquine against SARS-CoV-2. At present, there is insufficient"/>
 <result pre="in vitro studies reported the anti-viral activity of Chloroquine and" exact="hydroxychloroquine" post="against SARS-CoV-2. At present, there is insufficient in vivo"/>
 <result pre="in a particular individual. Based on the efficiency of the" exact="hydroxychloroquine" post="and chloroquine drugs, it should be approved soon as"/>
 <result pre="particular individual. Based on the efficiency of the hydroxychloroquine and" exact="chloroquine" post="drugs, it should be approved soon as the one-stop"/>
 <result pre="government professionals and should reduce their intake of smoking and" exact="alcohol" post="consumption in order to improve will improve their immunity."/>
 <result pre="Kidney DiseasesBethesda (MD)2017 Feb 2 18PlantoneDKoudriavtsevaT2018Current and future use of" exact="chloroquine" post="and hydroxychloroquine in infectious, immune, neoplastic and neurological diseases:"/>
 <result pre="(MD)2017 Feb 2 18PlantoneDKoudriavtsevaT2018Current and future use of chloroquine and" exact="hydroxychloroquine" post="in infectious, immune, neoplastic and neurological diseases: A Mini-ReviewClin"/>
 <result pre="and neurological diseases: A Mini-ReviewClin Drug Investig3865367110.1007/s40261-018-0656-y29737455 19YanYZouZSunYet al.2013Anti-malaria drug" exact="chloroquine" post="is highly effective in treating avian influenza A H5N1"/>
 <result pre="congenital microcephaly in miceEBioMedicine2418919410.1016/j.ebiom.2017.09.03429033372 21ShiryaevSAMesciPPintoAet al.2017Repurposing of the anti-malaria drug" exact="chloroquine" post="for Zika virus treatment and prophylaxisSci Rep71577110.1038/s41598-017-15467-629150641 22YaoXYeFZhangMet al.2020In"/>
 <result pre="vitro antiviral activity and projection of optimized dosing design of" exact="hydroxychloroquine" post="for the treatment of severe acute respiratory syndrome coronavirus"/>
 <result pre="syndrome coronavirus 2 (SARS-CoV-2)Clin Infect Dis[Online ahead of print]10.1093/cid/ciaa23732150618 23GaoJTianZYangX2020Breakthrough:" exact="chloroquine" post="phosphate has shown apparent efficacy in treatment of COVID-19"/>
 <result pre="of chloroquine. Focus on recent advancementsClin Pharmacokinet3125727410.2165/00003088-199631040-000038896943 26WangMCaoRZhangLet al.2020Remdesivir and" exact="chloroquine" post="effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in"/>
 <result pre="and spreadVirol J26910.1186/1743-422X-2-6916115318 28DevauxCARolainJMColsonPRaoultD2020New insights on the antiviral effects of" exact="chloroquine" post="against coronavirus: what to expect for COVID-19?Int J Antimicrob"/>
 <result pre="for COVID-19?Int J Antimicrob Agents[Online ahead of print]10.1016/j.ijantimicag.2020.10593832171740 29SavarinoABoelaertJRCassoneAMajoriGCaudaR2003Effectd of" exact="chloroquine" post="on viral infections: an old drug against today's diseasesLancet"/>
 <result pre="evidenceInt J Antimicrob Agents[Online ahead of print]10.1016/j.ijantimicag.2020.10594832201353 31GautretPLagierJCParolaPet al.2020Hydroxychloroquine and" exact="azithromycin" post="as a treatment of COVID-19: results of an open-label"/>
 <result pre="a laboratory for further processing. Fig. 2 Probable mechanism of" exact="hydroxychloroquine" post="(HC) against SARS-CoV-2: The figure depicts the mechanism of"/>
 <result pre="against SARS-CoV-2: The figure depicts the mechanism of action of" exact="hydroxychloroquine" post="targeting the SARS-CoV-2 through many ways. (1) The hydroxychloroquine"/>
 <result pre="of hydroxychloroquine targeting the SARS-CoV-2 through many ways. (1) The" exact="hydroxychloroquine" post="has the ability to constrain the quinone reductase-2 which"/>
 <result pre="used as the receptor moieties by the SARS-CoV-2. (2) The" exact="hydroxychloroquine" post="could change the pH of lysosomes that leads to"/>
 <result pre="ACE2 receptors and inhibits the viral infection. (4) Moreover, the" exact="hydroxychloroquine" post="obstructs the MAP-kinase pathway which results to SARS-CoV-2 virus"/>
 <result pre="Not yet recruiting - 2. Lopinavir/ritonavir tablets or Arbidol or" exact="Chloroquine" post="phosphate Efficacy and Safety of Corticosteroids in COVID-19 Methylprednisolone"/>
 <result pre="or Chloroquine phosphate Efficacy and Safety of Corticosteroids in COVID-19" exact="Methylprednisolone" post="Recruiting 1. Hubei province hospital of integrated Chinese &amp;amp;"/>
 <result pre="2019-nCoV Remdesivir RCT Remdesivir Recruiting Bin Cao; Beijing, Beijing, China" exact="Nitric Oxide" post="Gas Inhalation for Severe Acute Respiratory Syndrome in COVID-19"/>
 <result pre="Oxide Gas Inhalation for Severe Acute Respiratory Syndrome in COVID-19" exact="Nitric Oxide" post="Gas Not yet recruiting - Efficacy and Safety of"/>
 <result pre="Regional Medical left Everett, Everett, Washington, United States Lopinavir/ Ritonavir," exact="Ribavirin" post="and IFN-beta Combination for nCoV Treatment 1. Lopinavir/ritonavir Recruiting"/>
 <result pre="Lopinavir/ritonavir Recruiting University of Hong Kong, Queen Mary Hospital 2." exact="Ribavirin" post="Hong Kong, Hong Kong 3. Interferon Beta-1B Efficacy of"/>
 <result pre="Ribavirin Hong Kong, Hong Kong 3. Interferon Beta-1B Efficacy of" exact="Chloroquine" post="and Lopinavir/ Ritonavir in mild/general novel coronavirus (CoVID-19) infections:"/>
 <result pre="Hong Kong 3. Interferon Beta-1B Efficacy of Chloroquine and Lopinavir/" exact="Ritonavir" post="in mild/general novel coronavirus (CoVID-19) infections: a prospective, open-label,"/>
 <result pre="infections: a prospective, open-label, multileft randomized controlled clinical study 1." exact="Chloroquine" post="- The Fifth Affiliated Hospital Sun Yat-Sen University 2."/>
 <result pre="- The Fifth Affiliated Hospital Sun Yat-Sen University 2. Lopinavir/" exact="Ritonavir" post="A prospective, randomized, open-label, parallel controlled trial for the"/>
 <result pre="randomized, open-label, parallel controlled trial for the preventive effect of" exact="hydroxychloroquine" post="on medical personnel after exposure to COVID-19 Hydroxychloroquine -"/>
 <result pre="effect of hydroxychloroquine on medical personnel after exposure to COVID-19" exact="Hydroxychloroquine" post="- Renmin Hospital of Wuhan University Glucocorticoid Therapy for"/>
 <result pre="Novel Coronavirus Critically Ill Patients with Severe Acute Respiratory Failure" exact="Methylprednisolone" post="Recruiting Medical ICU,Peking Union Medical College HospitalBeijing, Beijing, China"/>
 <result pre="Medical University A prospective clinical study for recombinant human interferon" exact="alpha" post="1b spray in the prevention of novel coronavirus (COVID-19)"/>
 <result pre="(COVID-19) infection in highly exposed medical staffs recombinant human interferon" exact="alpha" post="1b - Chinese PLA General Hospital A Pilot Study"/>
 <result pre="Disease, Wuhan, Hubei, China A study for the efficacy of" exact="hydroxychloroquine" post="for mild and moderate COVID-19 infectious diseases Hydroxychloroquine -"/>
 <result pre="efficacy of hydroxychloroquine for mild and moderate COVID-19 infectious diseases" exact="Hydroxychloroquine" post="- The Second Affiliated Hospital of Chongqing Medical University"/>
 <result pre="Hospital of Chongqing Medical University The Efficacy and Safety of" exact="Thalidomide" post="Combined with Low-dose Hormones in the Treatment of Severe"/>
 <result pre="Combined with Low-dose Hormones in the Treatment of Severe COVID-19" exact="Thalidomide" post="Not yet recruiting - Various Combination of Protease Inhibitors,"/>
 <result pre="recruiting - Various Combination of Protease Inhibitors, Oseltamivir, Favipiravir, and" exact="Chloroquine" post="for Treatment of COVID19: A Randomized Control Trial Oral"/>
 <result pre="Minnesota, United States University of Minnesota, Minneapolis, Minnesota, United States" exact="Chloroquine" post="Prevention of Coronavirus Disease (COVID-19) in the Healthcare Setting"/>
 <result pre="Chloroquine Prevention of Coronavirus Disease (COVID-19) in the Healthcare Setting" exact="Chloroquine" post="Not yet recruiting - Favipiravir Combined with Tocilizumab in"/>
 <result pre="of Minnesota, Minneapolis, Minnesota, United States Comparison of Lopinavir/Ritonavir or" exact="Hydroxychloroquine" post="in Patients with Mild Coronavirus Disease (COVID-19) 1. Lopinavir/ritonavir"/>
 <result pre="Hydroxychloroquine in Patients with Mild Coronavirus Disease (COVID-19) 1. Lopinavir/ritonavir" exact="Hydroxychloroquine" post="sulfate Recruiting Asan Medical left, University of Ulsan College"/>
 <result pre="Korea, Republic of Korea Evaluation of Ganovo (Danoprevir) Combined with" exact="Ritonavir" post="in the Treatment of Novel Coronavirus Infection Ganovo with"/>
 <result pre="Ritonavir in the Treatment of Novel Coronavirus Infection Ganovo with" exact="ritonavir" post="+/-Interferon Recruiting The Ninth Hospital of Nanchang Nanchang, Jiangxi,"/>
 <result pre="Infected Patients Eculizumab Initiated - Norwegian Coronavirus Disease 2019 Study" exact="Hydroxychloroquine" post="Sulfate Not yet recruiting - Post-exposure Prophylaxis for SARS-Coronavirus-2"/>
 <result pre="Hydroxychloroquine Sulfate Not yet recruiting - Post-exposure Prophylaxis for SARS-Coronavirus-2" exact="Hydroxychloroquine" post="Recruiting University of Minnesota, Minneapolis, Minnesota, United States The"/>
 <result pre="Minnesota, Minneapolis, Minnesota, United States The efficacy and safety of" exact="pirfenidone" post="capsules in the treatment of severe new coronavirus pneumonia"/>
 <result pre="in the treatment of COVID-19 Name of Drug Illnesses treated" exact="Ribavirin" post="RSV and RSV pneumonia Reverse transcriptase inhibitors: zidovudine, didanosine,"/>
 <result pre="RSV pneumonia Reverse transcriptase inhibitors: zidovudine, didanosine, zalcitabine, stavudine, lamivudine," exact="abacavir" post="and emtricitabine SARS Cathespin L SARS Methylprednisolone SARS, MERS"/>
 <result pre="Reverse transcriptase inhibitors: zidovudine, didanosine, zalcitabine, stavudine, lamivudine, abacavir and" exact="emtricitabine" post="SARS Cathespin L SARS Methylprednisolone SARS, MERS Protease Inhibitors"/>
 <result pre="zalcitabine, stavudine, lamivudine, abacavir and emtricitabine SARS Cathespin L SARS" exact="Methylprednisolone" post="SARS, MERS Protease Inhibitors (PIs): saquinavir, ritonavir, indinavir, nelfinavir,"/>
 <result pre="MERS Protease Inhibitors (PIs): saquinavir, ritonavir, indinavir, nelfinavir, amprenavir, lopinavir," exact="atazanavir" post="and fosamprenavir SARS Fusion inhibitor: enfuvirtide. Lamivudine and adefovir"/>
 <result pre="Inhibitors (PIs): saquinavir, ritonavir, indinavir, nelfinavir, amprenavir, lopinavir, atazanavir and" exact="fosamprenavir" post="SARS Fusion inhibitor: enfuvirtide. Lamivudine and adefovir dipivoxil SARS"/>
 <result pre="nelfinavir, amprenavir, lopinavir, atazanavir and fosamprenavir SARS Fusion inhibitor: enfuvirtide." exact="Lamivudine" post="and adefovir dipivoxil SARS Baricitinib COVID-19 Umifenovir ARVI, influenza,"/>
 <result pre="glycoprotein (hCoV-EMC) SARS, Human Coronavirus Guanosine-analog RNA synthesis inhibitors Coronavirus" exact="Ritonavir" post="and lopinavir SARS, MERS Interferon Subtypes of Î²-1b, Î±-n1,"/>
 <result pre="SARS, Human Coronavirus Guanosine-analog RNA synthesis inhibitors Coronavirus Ritonavir and" exact="lopinavir" post="SARS, MERS Interferon Subtypes of Î²-1b, Î±-n1, Î±-n3, and"/>
 <result pre="SARS, MERS Favipiravir COVID-19 Darunavir COVID-19 Lopinavir COVID-19, SARS, MERS" exact="Alcohol" post="Vaporization/Nebulization Inhalation Therapy COVID-19 Chloroquine SARS, Human Coronavirus OC43"/>
 <result pre="COVID-19 Lopinavir COVID-19, SARS, MERS Alcohol Vaporization/Nebulization Inhalation Therapy COVID-19" exact="Chloroquine" post="SARS, Human Coronavirus OC43 Chloroquine phosphate; Arbidol COVID-19 ASC09"/>
 <result pre="Alcohol Vaporization/Nebulization Inhalation Therapy COVID-19 Chloroquine SARS, Human Coronavirus OC43" exact="Chloroquine" post="phosphate; Arbidol COVID-19 ASC09 ARDS, Respiratory distress syndrome, SARS,"/>
 <result pre="and COVID-19 Non-nucleoside reverse transcriptase inhibitors (NNRTIs): nevirapine, delavirdine and" exact="efavirenz" post="SARS Ruxolitinib COVID-19 Saquinavir SARS and Feline Coronavirus Relenza,"/>
 <result pre="Non-nucleoside reverse transcriptase inhibitors (NNRTIs): nevirapine, delavirdine and efavirenz SARS" exact="Ruxolitinib" post="COVID-19 Saquinavir SARS and Feline Coronavirus Relenza, Tamiflu, Amantadine"/>
 <result pre="transcriptase inhibitors (NNRTIs): nevirapine, delavirdine and efavirenz SARS Ruxolitinib COVID-19" exact="Saquinavir" post="SARS and Feline Coronavirus Relenza, Tamiflu, Amantadine Influenza virus"/>
 <result pre="SARS Ruxolitinib COVID-19 Saquinavir SARS and Feline Coronavirus Relenza, Tamiflu," exact="Amantadine" post="Influenza virus Indinavir SARS and COVID-19 Carfilzomib COVID-19 Oseltamivir"/>
 <result pre="Coronavirus Relenza, Tamiflu, Amantadine Influenza virus Indinavir SARS and COVID-19" exact="Carfilzomib" post="COVID-19 Oseltamivir COVID-19 Azvudine COVID-19 Baloxavir marboxil COVID-19 Thymosin"/>
 <result pre="Indinavir SARS and COVID-19 Carfilzomib COVID-19 Oseltamivir COVID-19 Azvudine COVID-19" exact="Baloxavir marboxil" post="COVID-19 Thymosin Î±1 MERS Nucleotide reverse transcriptase inhibitor: tenofovir"/>
 <result pre="Syncytial Virus, ARVI - Acute respiratory viral infections. Table 4" exact="Chloroquine" post="and its combination of drugs used in the treatment"/>
 <result pre="in the treatment of COVID-19 Study Particulars Drugs Dosage Reference" exact="Chloroquine" post="(C) phosphate against pneumonia caused by COVID-19 but need"/>
 <result pre="pneumonia caused by COVID-19 but need confirmation through randomized trials" exact="Chloroquine" post="phosphate Not specified 15 SARS-CoV-2 and blocked viral infection"/>
 <result pre="infection by increasing the endosomal pH required for viral fusion" exact="Chloroquine" post="1.13 Î¼M at half maximal concentration 27 (Nichol et"/>
 <result pre="Î¼M at half maximal concentration 27 (Nichol et al., 2020)" exact="Chloroquine" post="(C) and Hydroxychloroquine (HC) are under investigation in clinical"/>
 <result pre="maximal concentration 27 (Nichol et al., 2020) Chloroquine (C) and" exact="Hydroxychloroquine" post="(HC) are under investigation in clinical trials for pre-exposure"/>
 <result pre="and treatment of patients with mild, moderate, and severe COVID-19" exact="Chloroquine" post="and Hydroxychloroquine Not specified 8 C and HC inhibit"/>
 <result pre="of patients with mild, moderate, and severe COVID-19 Chloroquine and" exact="Hydroxychloroquine" post="Not specified 8 C and HC inhibit in vitro"/>
 <result pre="vitro antiviral activity of C and HC against SARS-CoV-2 reported" exact="Chloroquine" post="and Hydroxychloroquine Not specified 27 (Nichol et al., 2020);"/>
 <result pre="activity of C and HC against SARS-CoV-2 reported Chloroquine and" exact="Hydroxychloroquine" post="Not specified 27 (Nichol et al., 2020); 43 (Liu"/>
 <result pre="(Nichol et al., 2020); 43 (Liu et al., 2020) Prescribing" exact="Hydroxychloroquine" post="treatment on a large scale, and decided to perform"/>
 <result pre="at demonstrating that HC is effective in vivo against SARS-CoV-2" exact="Hydroxychloroquine" post="Not specified 31 (Parola et al., 2020) Azithromycinâ€&quot;suggested to"/>
 <result pre="2020) Azithromycinâ€&quot;suggested to act in combination with C/HC against SARs-CoV-2" exact="Azithromycin" post="+ Chloroquine + Hydroxychloroquine Not specified 31 (Parola et"/>
 <result pre="to act in combination with C/HC against SARs-CoV-2 Azithromycin +" exact="Chloroquine" post="+ Hydroxychloroquine Not specified 31 (Parola et al., 2020)"/>
 <result pre="in combination with C/HC against SARs-CoV-2 Azithromycin + Chloroquine +" exact="Hydroxychloroquine" post="Not specified 31 (Parola et al., 2020) Two drugs,"/>
 <result pre="specified 31 (Parola et al., 2020) Two drugs, remdesivir and" exact="chloroquine" post="phosphate, efficiently inhibited SARS-CoV-2 infection in vitro Remdesivir +"/>
 <result pre="chloroquine phosphate, efficiently inhibited SARS-CoV-2 infection in vitro Remdesivir +" exact="chloroquine" post="phosphate Not specified 27 (Nichol et al., 2020) COVID-19"/>
 <result pre="and without contraindications to chloroquine, be treated with 500 mg" exact="chloroquine" post="twice a day for ten days Chloroquine 500 mg"/>
 <result pre="with 500 mg chloroquine twice a day for ten days" exact="Chloroquine" post="500 mg twice a day 31 (Parola et al.,"/>
 <result pre="500 mg twice a day 31 (Parola et al., 2020)" exact="Hydroxychloroquine" post="is recommended for high-risk COVID-19 cases Hydroxychloroquine Not specified"/>
 <result pre="et al., 2020) Hydroxychloroquine is recommended for high-risk COVID-19 cases" exact="Hydroxychloroquine" post="Not specified 32 (Hoffman et al., 2006) HC and"/>
 <result pre="vitro and in small, poorly controlled or uncontrolled clinical studies" exact="Chloroquine" post="and Hydroxychloroquine Not specified 22 (Zhang et al., 2020)"/>
 <result pre="in small, poorly controlled or uncontrolled clinical studies Chloroquine and" exact="Hydroxychloroquine" post="Not specified 22 (Zhang et al., 2020) Reducing symptom"/>
 <result pre="promoting virus-negative seroconversion without any severe side effects in COVID-19" exact="Chloroquine" post="Not specified 23 (Yang et al., 2020)"/>
</results>
